These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33965182)
1. Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia. Ruggeri A; Galimard JE; Paina O; Fagioli F; Tbakhi A; Yesilipek A; Navarro JMF; Faraci M; Hamladji RM; Skorobogatova E; Al-Seraihy A; Sundin M; Herrera C; Rifón J; Dalissier A; Locatelli F; Rocha V; Corbacioglu S Transplant Cell Ther; 2021 May; 27(5):424.e1-424.e9. PubMed ID: 33965182 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. Ruggeri A; Labopin M; Bacigalupo A; Gülbas Z; Koc Y; Blaise D; Bruno B; Irrera G; Tischer J; Diez-Martin JL; Castagna L; Ciceri F; Mohty M; Nagler A Cancer; 2018 Apr; 124(7):1428-1437. PubMed ID: 29360162 [TBL] [Abstract][Full Text] [Related]
3. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Rashidi A; Hamadani M; Zhang MJ; Wang HL; Abdel-Azim H; Aljurf M; Assal A; Bajel A; Bashey A; Battiwalla M; Beitinjaneh AM; Bejanyan N; Bhatt VR; Bolaños-Meade J; Byrne M; Cahn JY; Cairo M; Ciurea S; Copelan E; Cutler C; Daly A; Diaz MA; Farhadfar N; Gale RP; Ganguly S; Grunwald MR; Hahn T; Hashmi S; Hildebrandt GC; Holland HK; Hossain N; Kanakry CG; Kharfan-Dabaja MA; Khera N; Koc Y; Lazarus HM; Lee JW; Maertens J; Martino R; McGuirk J; Munker R; Murthy HS; Nakamura R; Nathan S; Nishihori T; Palmisiano N; Patel S; Pidala J; Olin R; Olsson RF; Oran B; Ringden O; Rizzieri D; Rowe J; Savoie ML; Schultz KR; Seo S; Shaffer BC; Singh A; Solh M; Stockerl-Goldstein K; Verdonck LF; Wagner J; Waller EK; De Lima M; Sandmaier BM; Litzow M; Weisdorf D; Romee R; Saber W Blood Adv; 2019 Jun; 3(12):1826-1836. PubMed ID: 31201170 [TBL] [Abstract][Full Text] [Related]
5. Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study. Ruggeri A; Santoro N; Galimard JE; Kalwak K; Algeri M; Zubarovskaya L; Czyzewski K; Skorobogatova E; Sedlacek P; Besley C; Balduzzi A; Bertrand Y; Peristeri J; Fagioli F; Ifversen M; Gozdzik J; Peters C; Versluijs B; Biffi A; Prete A; Faraci M; Ghemlas I; Bodova I; Aleinikova O; Dalissier A; Rocha V; Corbacioglu S Haematologica; 2024 Jul; 109(7):2122-2130. PubMed ID: 38186346 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia. Nagler A; Dholaria B; Labopin M; Savani BN; Angelucci E; Koc Y; Arat M; Pioltelli P; Sica S; Gülbas Z; Tischer J; Bernasconi P; Pavlu J; Socié G; Blaise D; Rigacci L; Martino M; Diez-Martin JL; Perić Z; Giebel S; Mohty M Leukemia; 2020 Oct; 34(10):2766-2775. PubMed ID: 32393841 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT. Ruggeri A; Labopin M; Angelucci E; Blaise D; Ciceri F; Koc Y; Chiusolo P; Diez-Martin JL; Gülbas Z; Castagna L; Bruno B; Arat M; Martino M; Nagler A; Mohty M Bone Marrow Transplant; 2021 Aug; 56(8):1842-1849. PubMed ID: 33674790 [TBL] [Abstract][Full Text] [Related]
8. Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT. Rubio MT; Savani BN; Labopin M; Piemontese S; Polge E; Ciceri F; Bacigalupo A; Arcese W; Koc Y; Beelen D; Gülbas Z; Wu D; Santarone S; Tischer J; Afanasyev B; Schmid C; Giebel S; Mohty M; Nagler A J Hematol Oncol; 2016 Mar; 9():25. PubMed ID: 26980295 [TBL] [Abstract][Full Text] [Related]
9. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis. Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951 [TBL] [Abstract][Full Text] [Related]
10. Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT. Piemontese S; Boumendil A; Labopin M; Schmid C; Ciceri F; Arcese W; Koc Y; Gulbas Z; Tischer J; Bruno B; Wu D; Blaise D; Beelen D; Irrera G; Ruggeri A; Houhou M; Mohty M; Nagler A; J Hematol Oncol; 2019 Jul; 12(1):68. PubMed ID: 31272508 [TBL] [Abstract][Full Text] [Related]
11. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768 [TBL] [Abstract][Full Text] [Related]
12. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. Bazarbachi A; Labopin M; Angelucci E; Gülbas Z; Ozdogu H; Arat M; de Rosa L; Pastano R; Pioltelli P; Montserrat R; Martino M; Ciceri F; Koç Y; Socié G; Blaise D; Herrera C; Chalandon Y; Bernasconi P; Marotta G; Castagna L; McDonald A; Visani G; Carluccio P; Vitek A; Simand C; Afanasyev B; Rösler W; Diez-Martin JL; Nagler A; Brissot E; Giebel S; Mohty M Biol Blood Marrow Transplant; 2020 May; 26(5):936-942. PubMed ID: 31926364 [TBL] [Abstract][Full Text] [Related]
13. Donor KIR2DS1-Mediated Decreased Relapse and Improved Survival Depending on Remission Status at HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide. Ido K; Koh H; Hirose A; Okamura H; Koh S; Nanno S; Nishimoto M; Nakamae M; Nakashima Y; Nakane T; Hino M; Nakamae H Biol Blood Marrow Transplant; 2020 Apr; 26(4):723-733. PubMed ID: 31899360 [TBL] [Abstract][Full Text] [Related]
14. Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia. Rocha V; Arcuri LJ; Seber A; Colturato V; Zecchin VG; Kuwahara C; Nichele S; Gouveia R; Fernandes JF; Macedo AV; Tavares R; Daudt L; De Souza MP; Darrigo-Jr LG; Villela NC; Mariano LCB; Ginani VC; Zanette A; Loth G; Gomes AA; Hamerschlak N; Flowers ME; Bonfim C; Bone Marrow Transplant; 2021 Dec; 56(12):3042-3048. PubMed ID: 34548627 [TBL] [Abstract][Full Text] [Related]
15. Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts. Arcuri LJ; Hamerschlak N; Rocha V; Bonfim C; Kerbauy MN Transplant Cell Ther; 2021 Sep; 27(9):782.e1-782.e7. PubMed ID: 34146733 [TBL] [Abstract][Full Text] [Related]
16. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission. Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881 [TBL] [Abstract][Full Text] [Related]
17. Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients. Pagliardini T; Castagna L; Harbi S; Porta MD; Rey J; Fürst S; Bramanti S; Saillard C; Legrand F; Maisano V; Faucher C; Granata A; Hospital MA; Lining W; Weiller PJ; Calmels B; Charbonnier A; Lemarie C; Chabannon C; Vey N; Mokart D; Blaise D; Devillier R Biol Blood Marrow Transplant; 2019 Sep; 25(9):1803-1809. PubMed ID: 31128325 [TBL] [Abstract][Full Text] [Related]
18. Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Nagler A; Labopin M; Koc Y; Angelucci E; Tischer J; Arat M; Pioltelli P; Bernasconi P; Chiusolo P; Diez-Martin JL; Sanz J; Ciceri F; Peric Z; Giebel S; Canaani J; Mohty M Cancer; 2021 Jul; 127(14):2507-2514. PubMed ID: 33739471 [TBL] [Abstract][Full Text] [Related]
19. Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma. Mariotti J; Devillier R; Bramanti S; Giordano L; Sarina B; Furst S; Granata A; Maisano V; Pagliardini T; De Philippis C; Kogan M; Faucher C; Harbi S; Chabannon C; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D; Castagna L Biol Blood Marrow Transplant; 2019 Sep; 25(9):1810-1817. PubMed ID: 31128326 [TBL] [Abstract][Full Text] [Related]
20. Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide. Mariotti J; Taurino D; Marino F; Bramanti S; Sarina B; Morabito L; De Philippis C; Di Vito C; Mavilio D; Carlo-Stella C; Della Porta M; Santoro A; Castagna L Cancer Med; 2020 Jan; 9(1):52-61. PubMed ID: 31702882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]